84 related articles for article (PubMed ID: 3972760)
1. Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts.
Rolston K; Bolivar R; Fainstein V; Jones P; Elting L; Bodey GP
J Antimicrob Chemother; 1985 Jan; 15(1):91-6. PubMed ID: 3972760
[TBL] [Abstract][Full Text] [Related]
2. Ceftizoxime plus ticarcillin: double beta-lactam therapy for infections in cancer patients.
Rolston KV; Jones PG; Fainstein V; Elting L; Bodey GP
J Antimicrob Chemother; 1987 Mar; 19(3):367-71. PubMed ID: 3471752
[TBL] [Abstract][Full Text] [Related]
3. The use of cefotaxime in the treatment of gram-positive pneumonias.
Jenkinson SG
Infection; 1985; 13 Suppl 1():S14-7. PubMed ID: 4055045
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the effect of cefotaxime in senile pneumonia caused by gram-positive and gram-negative bacteria.
Katsunuma H
Infection; 1985; 13 Suppl 1():S18-24. PubMed ID: 4055049
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
[TBL] [Abstract][Full Text] [Related]
6. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Fainstein V; Bodey GP; Elting L; Bolivar R; Keating MJ; McCredie KB; Valdivieso M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():101-10. PubMed ID: 6352612
[TBL] [Abstract][Full Text] [Related]
8. Cefoperazone for the treatment of infections in patients with cancer.
Bolivar R; Fainstein V; Elting L; Bodey GP
Rev Infect Dis; 1983; 5 Suppl 1():S181-7. PubMed ID: 6221389
[TBL] [Abstract][Full Text] [Related]
9. Cefotaxime for the treatment of gram-positive urinary tract infection.
Piccinno A; Pagliarulo A
Infection; 1985; 13 Suppl 1():S100-2. PubMed ID: 4055038
[TBL] [Abstract][Full Text] [Related]
10. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
[TBL] [Abstract][Full Text] [Related]
11. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
[TBL] [Abstract][Full Text] [Related]
12. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
Karakusis PH; Trenholme GM; Levin S
Infection; 1985; 13 Suppl 1():S46-9. PubMed ID: 4055055
[TBL] [Abstract][Full Text] [Related]
13. Ceftizoxime in the treatment of infections in patients with cancer.
Fainstein V; Bolivar R; Elting L; Valdivieso M; Bodey GP
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():167-73. PubMed ID: 6296002
[No Abstract] [Full Text] [Related]
14. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
[TBL] [Abstract][Full Text] [Related]
15. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
Iannini PB
Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of cefotaxime in gram-positive surgical infections.
Wittmann DH; Frommelt L
Infection; 1985; 13 Suppl 1():S37-42. PubMed ID: 4055054
[TBL] [Abstract][Full Text] [Related]
17. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
Lode H; Glatzel PD
Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience of cefotaxime (author's transl)].
Portier H; Carbon C; Boussougant Y; Destaing F
Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience in the diagnosis and treatment of infections in the compromised host.
Cone LA; Woodard D; Helm NA
Clin Ther; 1981; 4 Suppl A():45-54. PubMed ID: 6275997
[TBL] [Abstract][Full Text] [Related]
20. Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporins.
Rolston KV; Jones PG; Fainstein V; Khardori NM; Anaissie EJ; Steelhammer L; Bodey GP
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):139-45. PubMed ID: 2060514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
